Scolr Pharma adds Nuprin to portfolio

BOTHELL, Wash. Scolr Pharma earlier this year acquired the rights to the Nuprin brand name from Advanced Healthcare Distributors, an affiliate company of CVS Caremark, in a deal worth $180,000.

“Our acquisition of this globally recognized name will provide us with additional opportunities for ibuprofen-based products,” stated Stephen Turner, Scolr Pharma president and CEO. “We expect that the acquisition will allow us to generate potential near-term sales of immediate release 200 mg ibuprofen tablets, in addition to providing us with enhanced options on our extended release ibuprofen program.”